Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Retroviruses

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

RNA Interference

RNA Interference

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

3D heterotypic models of glioblastoma reveal the impact of microglia on cellular organization and the production of a distinct secretome.

Scientific reports·2026

Same author

SNUPN-Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights.

Annals of clinical and translational neurology·2025

Same author

Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group.

Molecular therapy. Nucleic acids·2025

Same author

Author Correction: Uncovering functional lncRNAs by scRNA-seq with ELATUS.

Nature communications·2025

Same author

Uncovering functional lncRNAs by scRNA-seq with ELATUS.

Nature communications·2024

Same author

Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis.

Acta neuropathologica·2024

Search research articles

Related Experiment Video

Updated: Apr 16, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

U1 interference (U1i) for antiviral approaches.

Lorea Blázquez¹, Puri Fortes

¹Department of Gene Therapy and Hepatology, Center for Applied Medical Research, Pio XII 55, Pamplona, Navarra, 31008, Spain.

Advances in Experimental Medicine and Biology

|March 12, 2015

Summary

This summary is machine-generated.

U1 interference (U1i) uses modified U1 small nuclear ribonucleoprotein (snRNP) to inhibit gene expression by blocking polyadenylation. Combining U1i with RNA interference offers potent antiviral therapy with reduced resistance and side effects.

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Related Experiment Videos

Last Updated: Apr 16, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Area of Science:

Molecular Biology
Gene Regulation
RNA Processing

Background:

U1 small nuclear ribonucleoprotein (snRNP) is crucial for mRNA splicing and 3'-end processing.
U1 snRNP binding near polyadenylation sites (PAS) influences mRNA processing and gene expression.
U1 interference (U1i) leverages U1 snRNP's inhibitory role in polyadenylation for gene silencing.

Purpose of the Study:

To explore U1 interference (U1i) as a gene silencing technique.
To evaluate the synergistic potential of combining U1i with RNA interference (RNAi) for enhanced gene inhibition.
To assess the application of U1i and U1i/RNAi combinations as antiviral therapies.

Main Methods:

Expression of a modified U1 snRNP to target specific genes upstream of their PAS.
Application of U1i in tissue culture and animal models to inhibit reporter and endogenous genes.
Combination of U1i with RNA interference (RNAi) for synergistic gene silencing effects.

Main Results:

U1i effectively inhibits gene expression by preventing polyadenylation.
The combination of U1i and RNAi demonstrates synergistic gene inhibition.
U1i has been successfully used to inhibit HIV-1 and HBV expression, with combined U1i/RNAi showing strong in vivo inhibition of HBV.

Conclusions:

U1i is a promising technique for gene expression inhibition.
The combination of U1i and RNAi offers enhanced gene silencing with potential for reduced resistance and off-target effects.
U1i and its combination with RNAi hold significant potential as novel antiviral strategies.